Literature DB >> 7021278

The acute metabolic effects of glucagon and its interactions with insulin in forearm tissue.

S H Schneider, S E Fineberg, G L Blackburn.   

Abstract

The acute effects of glucagon (mol. wt. 3500) and its interactions with insulin were studied in the forearm during eight studies in seven normal, post-absorptive males. The protocol consisted of a 2 h baseline, 1 h glucagon perfusion (mean glucagon increment, 691 +/- 50 pg/ml), 1 h perfusion of both insulin and glucagon (mean insulin increment of 105 insulin and glucagon (mean insulin increment of 105 /- 13 mU/l) and a 30 min recovery period. Simultaneous arterial (A), deep venous (DV), and superficial venous (SV) blood samples were obtained at 30 min intervals. Perfusion of glucagon resulted in a decrease in (A-DV) non-esterified fatty acids of -0.128 +/- 0.057 mmol/l (n = 7, p less than 0.05) and (A-SV) non-esterified fatty acids of -0.081 +/- 0.36 mol/l (n = 7, p less than 0.05), as well as a change in deep compartment uptake of glycerol after 60 min of -0.044 +/- 0.019 mumol/min/100 ml of forearm tissue (n=6, p less than 0.05), indicating increased lipolysis. There was also a decrease in net glucose uptake as reflected by a change in (A-Dids of -0.081 +/- 0.36 mol/l (n = 7, p less than 0.05), as well as a change in deep compartment uptake of glycerol after 60 min of -0.044 +/- 0.019 mumol/min/100 ml of forearm tissue (n=6, p less than 0.05), indicating increased lipolysis. There was also a decrease in net glucose uptake as reflected by a change in (A-Dids of -0.081 +/- 0.36 mol/l (n = 7, p less than 0.05), as well as a change in deep compartment uptake of glycerol after 60 min of -0.044 +/- 0.019 mumol/min/100 ml of forearm tissue (n=6, p less than 0.05), indicating increased lipolysis. There was also a decrease in net glucose uptake as reflected by a change in (A-DV) of -0.24 +/- 0.09 mmol/l (n = 7, p less than 0.025) and (A-SV) of 0.10 +/- 0.05 mmol/l (n = 7, p less than 0.05). There was also a net decrease in deep arteriovenous differences of potassium in six of seven subjects. Insulin levels, similar to those found after a meal, rapidly reversed the effects of glucagon on non-esterified fatty acid, glucose and potassium. These effects persisted throughout the recovery period.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7021278     DOI: 10.1007/bf00257430

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  33 in total

1.  Elevation of plasma epinephrine levels produced by glucagon in vivo.

Authors:  E J SARCIONE; N BACK; J E SOKAL; B MEHLMAN; E KNOBLOCK
Journal:  Endocrinology       Date:  1963-04       Impact factor: 4.736

2.  Effects of glucagon on plasma potassium.

Authors:  S K WOLFSON; S ELLIS
Journal:  Proc Soc Exp Biol Med       Date:  1956-02

Review 3.  Glucagon and diabetes: a reappraisal.

Authors:  P J Lefebvre; A S Luyckx
Journal:  Diabetologia       Date:  1979-06       Impact factor: 10.122

4.  Quantitative aspects of blood flow and oxygen uptake in the human forearm during rhythmic exercise.

Authors:  J Wahren
Journal:  Acta Physiol Scand Suppl       Date:  1966

5.  The contribution of endogenous insulin secretion to the ketogenic response to glucagon in man.

Authors:  D S Schade; R P Eaton
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

6.  Modulation of fatty acid metabolism by glucagon in man. I. Effects in normal subjects.

Authors:  D S Schade; R P Eaton
Journal:  Diabetes       Date:  1975-05       Impact factor: 9.461

7.  Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.

Authors:  R S Sherwin; C Bastl; F O Finkelstein; M Fisher; H Black; R Hendler; P Felig
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

8.  Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon.

Authors:  J E Gerich; M Lorenzi; D M Bier; V Schneider; E Tsalikian; J H Karam; P H Forsham
Journal:  N Engl J Med       Date:  1975-05-08       Impact factor: 91.245

9.  Effects of glucagon on lipolysis and ketogenesis in normal and diabetic men.

Authors:  J E Liljenquist; J D Bomboy; S B Lewis; B C Sinclair-Smith; P W Felts; W W Lacy; O B Crofford; G W Liddle
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

10.  Effects of fatty acids on carbohydrate and fatty acid metabolism of rat diaphragm.

Authors:  G Schonfeld; D M Kipnis
Journal:  Am J Physiol       Date:  1968-08
View more
  5 in total

1.  Hyperaminoacidaemia reduces insulin-mediated glucose disposal in healthy man.

Authors:  P Tessari; S Inchiostro; G Biolo; E Duner; R Nosadini; A Tiengo; G Crepaldi
Journal:  Diabetologia       Date:  1985-11       Impact factor: 10.122

2.  The effect of glucagon administration on protein synthesis in skeletal muscles, heart and liver in vivo.

Authors:  V R Preedy; P J Garlick
Journal:  Biochem J       Date:  1985-06-15       Impact factor: 3.857

3.  Hyperglucagonemia and insulin-mediated glucose metabolism.

Authors:  S Del Prato; P Castellino; D C Simonson; R A DeFronzo
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

4.  Idiopathic reactive hypoglycemia: a role for glucagon?

Authors:  F Leonetti; L Morviducci; A Giaccari; P Sbraccia; S Caiola; D Zorretta; O Lostia; G Tamburrano
Journal:  J Endocrinol Invest       Date:  1992-04       Impact factor: 4.256

5.  Glucagon Receptor Signaling and Lipid Metabolism.

Authors:  Katrine D Galsgaard; Jens Pedersen; Filip K Knop; Jens J Holst; Nicolai J Wewer Albrechtsen
Journal:  Front Physiol       Date:  2019-04-24       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.